Status:
RECRUITING
Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Vasorin
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Septic shock is the most severe form of infection. Currently, an early specific biomarker for septic shock is needed. Remember that shock situations are numerous, not only septic (eg hemorrhagic, card...
Eligibility Criteria
Inclusion
- Adults over 18 years.
- Patients admitted for less than 24 hours in intensive care unit of the CHU Amiens Picardie.
- Group 1: patients with septic shock defined by sepsis with 2 mmol/l Lactates, requiring vasopressors to maintain mean blood pressure at 65 mmHg (despite adequate vascular filling) in the presence of fever (T°\>38.3) with a documented or suspected infection
- Group 2: patients with a shock defined by arterial hypotension requiring the use of vasopressors with 2 mmol/l Lactates but without suspected infection and apyrexie (T°\<38°). For example: vasoplegia post cardiac surgery with CBP or cardiogenic shock or hemorrhagic shock
Exclusion
- Pregnant women
- Group 1 : No evidence of suspected or documented infection
- Group 2 : Presence of fever and/or suspected infection
Key Trial Info
Start Date :
October 19 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT07203833
Start Date
October 19 2025
End Date
May 1 2027
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens-Picardie
Amiens, France, 80000